> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Canopy Growth Revenue Rises 22% As International Cannabis Sales Jump 141%, But Net Loss Widens To C$40.7 Million
- URL: https://www.bullished.co/canopy-growth-revenue-rises-22-as-international-cannabis-sales-jump-141-but-net-loss-7b532365/
- Published: 2026-11-06T12:15:41.000Z
- Updated: 2026-11-06T12:15:41.000Z
- Description: A C$35.8 million fair value charge on Canopy USA assets swamped a quarter of growth, and the CFO says positive adjusted EBITDA is within reach.
- Author: Matteo Parrino
- Tags: Earnings, CGC, Industry: Healthcare

[Canopy Growth](https://www.bullished.co/tag/cgc/), which grows and sells cannabis mainly in Canada, [reported net revenue of C$81.4 million](https://www.sec.gov/Archives/edgar/data/0001737927/000119312526450716/cgc-ex99%5F1.htm?ref=bullished.co) for its fiscal second quarter, up 22% from a year earlier. Its net loss still widened to C$40.7 million from C$5.0 million, which the company blamed on C$35.8 million of fair value charges on assets tied to Canopy USA.

## Europe leads a broad revenue gain

The Cannabis segment grew 30% to C$66.2 million. International cannabis sales rose 141% to C$12.3 million from C$5.1 million, which the company attributed mainly to medical cannabis sales in Germany and Poland.

Canada medical cannabis revenue climbed 18% to C$25.8 million, helped by more insured customers and the MTL Cannabis acquisition, and partly offset by a cut in the Veterans Affairs Canada reimbursement rate. Canada adult-use revenue rose 17% to C$28.1 million, mainly on flower sales from MTL Cannabis, partly offset by lower opportunistic bulk sales.

Storz & Bickel, the company's vaporizer business, fell 4% to C$15.1 million as customers in some regions spent less.

## Margins slip and the loss balloons

Consolidated gross margin was 29%, against 33% a year earlier. Adjusted gross margin was 31%; the company excluded C$2.1 million of inventory step-up charges from the MTL deal. Cannabis gross margin fell to 26% from 31%. Selling, general and administrative costs rose 9%, driven by MTL's operations and partly offset by headcount cuts.

The net loss rose by C$35.7 million, which the company tied to C$35.8 million of fair value charges on Canopy USA related assets. Canopy Growth holds a non-controlling, non-voting interest in Canopy USA, an entity that participates in US cannabis sales.

## The path to positive adjusted EBITDA

Adjusted EBITDA, a profit measure that strips out items such as depreciation and stock pay, was a loss of C$2.9 million, C$0.2 million better than a year earlier. Free cash outflow narrowed to C$15.5 million from C$19.2 million.

CFO Tom Stewart said the company is "progressing steadily to profitability" and within reach of positive adjusted EBITDA during fiscal 2027\. CEO Luc Mongeau pointed to a U.K. market entry, a new German country manager and EU GMP certification of the Smiths Falls facility.

Cash and equivalents stood at C$247.3 million at September 30, down from C$364.7 million at March 31.

Management discusses the results on a call at 10:00 a.m. ET Friday, with a replay available until February 4, 2027.

Learn

- [Item 2.02: results of operations →](https://www.bullished.co/learn/8-k-items-explained/#item-202-results-of-operations)  
From 8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples

### Sources

- [8-K Filing — Canopy Growth Corp (CGC)](https://www.sec.gov/Archives/edgar/data/0001737927/000119312526450716/cgc-20261106.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit cgc-ex99\_1.htm — Canopy Growth Corp 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0001737927/000119312526450716/cgc-ex99%5F1.htm?ref=bullished.co) — SEC EDGAR
- [Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026 – Company Announcement - FT.com](https://markets.ft.com/data/announce/detail?dockey=600-202610220700BIZWIRE%5FUSPRX%5F%5F%5F%5F20261022%5FBW419511-1&ref=bullished.co) — Financial Times

### More on Canopy Growth

- [Canopy Growth — Once Worth $17 Billion — Has 6 Months To Lift Its Stock Back Above $1 Or Face Nasdaq Delisting Steps](https://www.bullished.co/canopy-growth-once-worth-17-billion-has-6-months-to-lift-its-stock-back-above-1-or-face-nasdaq-delisting-steps/)
- [Canopy Growth Has Until April 12, 2027 To Lift Shares Back To $1.00 After Nasdaq Warning](https://www.bullished.co/canopy-growth-has-until-april-12-2027-to-lift-shares-back-to-1-00-after-nasdaq-warning-b8732f24/)
- [Canopy Growth Meeting Fell Short Of Quorum; Reconvenes October 23 After Vote Reminder](https://www.bullished.co/canopy-growth-meeting-fell-short-of-quorum-reconvenes-october-23-after-vote-reminder-f0899173/)

[All Canopy Growth (CGC) coverage →](https://www.bullished.co/tag/cgc/)